210 related articles for article (PubMed ID: 33623381)
21. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
[TBL] [Abstract][Full Text] [Related]
22. A carbohydrate mimetic peptide modified size-shrinkable micelle nanocluster for anti-tumor targeting and penetrating drug delivery.
Chen Q; Liang H; Sun Y; Chen Y; He W; Fang X; Sha X; Li J
Int J Nanomedicine; 2019; 14():7339-7352. PubMed ID: 31686810
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.
Guimarães PPG; Gaglione S; Sewastianik T; Carrasco RD; Langer R; Mitchell MJ
ACS Nano; 2018 Feb; 12(2):912-931. PubMed ID: 29378114
[TBL] [Abstract][Full Text] [Related]
24. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
Wei W; Lv PP; Chen XM; Yue ZG; Fu Q; Liu SY; Yue H; Ma GH
Biomaterials; 2013 May; 34(15):3912-23. PubMed ID: 23453062
[TBL] [Abstract][Full Text] [Related]
25. Presentation and Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand via Elongated Plant Viral Nanoparticle Enhances Antitumor Efficacy.
Le DHT; Commandeur U; Steinmetz NF
ACS Nano; 2019 Feb; 13(2):2501-2510. PubMed ID: 30668110
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation.
Wang K; Lei Y; Xia D; Xu P; Zhu T; Jiang Z; Ma Y
Colloids Surf B Biointerfaces; 2020 Apr; 188():110755. PubMed ID: 31887646
[TBL] [Abstract][Full Text] [Related]
27. Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery.
Zhang Y; Tan X; Ren T; Jia C; Yang Z; Sun H
Carbohydr Polym; 2018 Oct; 198():76-85. PubMed ID: 30093044
[TBL] [Abstract][Full Text] [Related]
28. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.
Yoon HY; Koo H; Choi KY; Chan Kwon I; Choi K; Park JH; Kim K
Biomaterials; 2013 Jul; 34(21):5273-80. PubMed ID: 23591396
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors.
Tummala S; Gowthamarajan K; Satish Kumar MN; Wadhwani A
Drug Deliv; 2016 Jun; 23(5):1773-87. PubMed ID: 26377238
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
31. Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy.
Zhang W; Yu M; Xi Z; Nie D; Dai Z; Wang J; Qian K; Weng H; Gan Y; Xu L
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46614-46625. PubMed ID: 31747243
[TBL] [Abstract][Full Text] [Related]
32. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
34. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
35. Transferrin-conjugated pH-sensitive platform for effective delivery of porous palladium nanoparticles and paclitaxel in cancer treatment.
Nguyen HT; Soe ZC; Yang KY; Phung CD; Nguyen LT; Jeong JH; Jin SG; Choi HG; Ku SK; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2019 Apr; 176():265-275. PubMed ID: 30623814
[TBL] [Abstract][Full Text] [Related]
36. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
37. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
38. Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma.
Zhao Q; Jiang D; Sun X; Mo Q; Chen S; Chen W; Gui R; Ma X
J Nanobiotechnology; 2021 Jun; 19(1):179. PubMed ID: 34120620
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
40. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
